CD8A and HTLV-2 infection: Since no treatment is available for HTLV-2 infection and host immunity is not sufficient to eradicate this virus, it is possible that the rate of infection is going to rise due to the presence of accumulative HTLV-2 reservoirs in host CD8+ T cells.